A 27-Year Experience with Atrioventricular Septal Defect Correction
- PMID: 40154545
- PMCID: PMC11970461
- DOI: 10.1055/a-2536-8640
A 27-Year Experience with Atrioventricular Septal Defect Correction
Abstract
This single-center study investigated long-term outcomes after surgical correction of atrioventricular septal defect (AVSD).A total of 248 patients underwent biventricular repair for AVSD between 1995 and 2022. A total of 208 (83.9%) patients had complete (cAVSD), 29 (11.7%) partial (pAVSD), and 11 (4.4%) transitional AVSD (tAVSD). Associated cardiovascular anomalies were present in 88 (35.5%) cases and 61 (24.6%) patients were born prematurely. Median age at repair was 7.1 for cAVSD, 23.7 for pAVSD, and 13 months for tAVSD.Overall survival or reoperation incidence did not differ significantly between AVSD types and improved significantly over surgical eras. Survival of the entire cohort was 88.3% at 10, 83.8% at 15, and 79.6% at 25 years. Prematurity (hazard ratio [HR]: 2.43, p = 0.029), low weight (<4 kg) (HR: 3.05, p = 0.028), and partial cleft closure (HR: 2.43, p = 0.037) were independent risk factors for mortality. Forty-eight patients (19.4%) underwent a total of 64 reoperations over the study period. The main indication for reoperation was left atrioventricular valve regurgitation (LAVVR) with 55/64 procedures. However, 36% of procedures were performed to address several lesions, with left ventricular outflow tract obstruction being the second most common indication. Freedom from reoperation was 78.2, 75.8, and 72.5% at 10, 15, and 25 years, respectively. The incidence of reoperation increased significantly in association with early postoperative LAVVR ≥ I-II° (HR: 2.6, 95% confidence interval [CI]: 1.4-4.7, p = 0.002) and presence of residual cardiac defects (HR: 2.0, 95% CI: 1.1-3.6, p = 0.018).While LAVVR is the main indication for reoperation, a significant proportion of procedures address additional pathologies. Premature patients and those with associated cardiovascular anomalies should receive special attention during postoperative follow-up.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Conflict of interest statement
None declared.
Figures
References
-
- Jacobs J P, Franklin R CG, Béland M J et al. Nomenclature for pediatric and congenital cardiac care: unification of clinical and administrative nomenclature - the 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11) Cardiol Young. 2021;31(07):1057–1188. - PubMed
-
- Buratto E, Lui A, Hu T et al. Propensity score matched analysis of cleft closure in complete atrioventricular septal defect repair. Ann Thorac Surg. 2022;113(05):1553–1561. - PubMed
-
- Ginde S, Lam J, Hill G D et al. Long-term outcomes after surgical repair of complete atrioventricular septal defect. J Thorac Cardiovasc Surg. 2015;150(02):369–374. - PubMed
-
- Hoohenkerk G J, Bruggemans E F, Koolbergen D R, Rijlaarsdam M E, Hazekamp M G. Long-term results of reoperation for left atrioventricular valve regurgitation after correction of atrioventricular septal defects. Ann Thorac Surg. 2012;93(03):849–855. - PubMed
-
- Shuhaiber J, Shin A Y, Gossett J G et al. Surgical management of neonatal atrioventricular septal defect with aortic arch obstruction. Ann Thorac Surg. 2013;95(06):2071–2077. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
